Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 368

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 368
---
     | the risk that, because the TuHURA Share Value is fixed and will not fluctuate for changes in the market price of Kineta Common Stock or TuHURA Common Stock, the then-current trading price of the shares of TuHURA Common Stock to be issued to holders of shares of Kineta Common Stock upon the consummation of the Mergers could be significantly higher than the TuHURA Share Value ; |

| • |     | the risk that Kineta’s financial performance may not meet TuHURA’s expectations; |

| • |     | the risk that the Mergers may not be completed or may be delayed despite the parties’ efforts, including the possibility that conditions to the parties’ obligations to complete the Mergers may not be satisfied, and the potential resulting disruptions to TuHURA’s and Kineta’s businesses; |

| • |     | the potential challenges and difficulties in integrating the operations of TuHURA and Kineta and the risk that anticipated cost savings and operational efficiencies between the two companies, or other anticipated cost benefits of the Mergers, might not be realized or might take longer to realize than expected; |

| • |     | the possible diversion of management attention for an extended period of time during the pendency of the Mergers and, following Closing, the integration of the two companies; |

| • |     | the effect that the length of time from announcement of the Mergers until consummation of the Mergers could have on the market price of TuHURA Common Stock and the relationship with TuHURA’s employees, stockholders, customers, suppliers, regulators and others who do business with TuHURA; |

| • |     | the Kineta stockholders may not approve the Merger Agreement Proposal; |

| • |     | the substantial costs to be incurred in connection with the Mergers, including those incurred regardless of whether the Mergers are consummated; |

| • |     | that there are limited circumstances in which the TuHURA Board of Directors may terminate the Merger Agreement; |

| • |     | that TuHURA would be required to pay to Kineta a termination fee of $1,000,000 in the event the Merger Agreement were to be terminated because of TuHURA’s failure to close the Concurrent Investment and obtain gross proceeds not less than $20,000,000 therefrom before the outside date; |

| • |     | the potential impact on the market price of TuHURA